22-Mar-2012

The UK banks on research and science

Abstract

UK industry is currently beset by high business costs, overly cautious lending and government austerity measures. But some support for r&d has been forthcoming through recent UK Government funding and tax credits, while regional grants are encouraging investment in some areas. The pharmaceutical industry accounts for 60% of r&d spending in the UK, but other sectors such as healthcare, automotive and the space industry, are offering opportunities for cleanroom suppliers.

The hub of Stevenage Bioscience Catalyst – the UK’s first open innovation bioscience campus

The economic slump has meant a tough time for UK cleanroom design companies. Susan Birks reports on changing UK policies and funding that may boost future business.

The UK may have the world’s sixth largest economy, but its economic focus for the past decade has been on financial services at the expense of manufacturing. Only now, following the banking crisis, is consideration being given to whether the UK might benefit from a more robust manufacturing industry. Funding that would boost sectors such as pharma, life sciences, medical devices, electronics and aerospace would certainly be welcomed by UK cleanroom designers and suppliers.

The life sciences sector is a highlight in an otherwise lacklustre performance from UK industry, which is currently beset by high business costs, overly cautious lending and government austerity measures. The ever more inter-dependent life science, pharma and biotech sectors have found it increasingly costly to maintain or build large facilities in Europe, but some support for r&d has been forthcoming through recent UK Government funding and tax credits.

. . .

This is a small extract of the full article which is available ONLY to subscribers. Subscribers sign-in (top right) to read the article.

Or

Subscribe now to Cleanroom Technology

Email this story